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Abstract
Developed over six decades ago, pulmonary oscillometry has re-emerged as a
noninvasive and effort-independent method for evaluating respiratory-system
impedance in patients with obstructive lung disease. Here, we evaluated the
relationships between hyperpolarized 3He ventilation-defect-percent (VDP)
and respiratory-system resistance, reactance and reactance area (AX) measure-
ments in 175 participants including 42 never-smokers without respiratory
disease, 56 ex-smokers with chronic-obstructive-pulmonary-disease (COPD),
28 ex-smokers without COPD and 49 asthmatic never-smokers. COPD partic-
ipants were dichotomized based on x-ray computed-tomography (CT)
evidence of emphysema (relative-area CT-density-histogram ≤ 950HU (RA950)
≥ 6.8%). In asthma and COPD subgroups, MRI VDP was significantly related
to the frequency-dependence of resistance (R5-19; asthma: q = 0.48,
P = 0.0005; COPD: q = 0.45, P = 0.0004), reactance at 5 Hz (X5: asthma,
q = 0.41, P = 0.004; COPD: q = 0.38, P = 0.004) and AX (asthma:
q = 0.47, P = 0.0007; COPD: q = 0.43, P = 0.0009). MRI VDP was also sig-
nificantly related to R5-19 in COPD participants without emphysema
(q = 0.54, P = 0.008), and to X5 in COPD participants with emphysema
(q = 0.36, P = 0.04). AX was weakly related to VDP in asthma (q = 0.47,
P = 0.0007) and COPD participants with (q = 0.39, P = 0.02) and without
(q = 0.43, P = 0.04) emphysema. AX is sensitive to obstruction but not speci-
fic to the type of obstruction, whereas the different relationships for MRI
VDP with R5-19 and X5 may reflect the different airway and parenchymal
disease-specific biomechanical abnormalities that lead to ventilation defects.
Introduction
First developed over 60 years ago (Dubois et al. 1956),
oscillometry has re-emerged as a way to generate clinical
measurements in patients with obstructive lung disease
because minimal coaching and patient effort is required.
Moreover, oscillometry is well-tolerated in young and old
patients across disease severities (Smith et al. 2005) and is
sensitive to small airway abnormalities (Peslin and Fred-
berg 1986). Oscillometry also provides a noninvasive way
(Oostveen et al. 2003) to reveal lung pathologies that
result in ventilation heterogeneity (Otis et al. 1956;
Lutchen and Gillis 1997; Kaczka et al. 2011) by directly
measuring resistance and reactance as functions of fre-
quency. It is well established that in asthma, respiratory-
system resistance responds to bronchodilator inhalation
(van Noord et al. 1994; Zerah et al. 1995; Kaczka et al.
1999; Delacourt et al. 2000) and is frequency-dependent
(Grimby et al. 1968; Bhansali et al. 1979; Brochard et al.
1987). The frequency dependence of resistance has also
been observed in patients with chronic obstructive pul-
monary disease (COPD) (di Mango et al. 2006), in whom
low-frequency resistance also diminishes after bronchodi-
lation (van Noord et al. 1994; Zerah et al. 1995).
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In patients with asthma and COPD, reactance is more
negative at low frequencies (Clement et al. 1983). The
area under the reactance curve can be quantified as the
reactance area (AX) (Goldman 2001) which is determined
by the reactance value measured at the lowest frequency,
the resonant frequency, and the shape of the low-fre-
quency reactance curve. AX measurements correlate
strongly with the frequency dependence of resistance
(Skloot et al. 2004) and in asthmatics, AX detects bron-
chodilator (van Noord et al. 1994) and bronchial chal-
lenge (van Noord et al. 1989) responses in the absence of
low-frequency reactance changes. Furthermore, AX has
been suggested as a useful tool for early disease screening
and monitoring in COPD, and may be more sensitive to
therapy response than the frequency dependence of resis-
tance (Lipworth and Jabbal 2018).
X-ray computed tomography (CT) airway measure-
ments were previously shown to be related to oscillometry
measurements of resistance in asthma (Karayama et al.
2018) and COPD (Karayama et al. 2017). Quantitative CT
measurements of emphysema have also been shown to be
related to oscillometry-measured reactance in COPD (Kar-
ayama et al. 2017) and there are differences in the relation-
ships between CT measurements and respiratory
impedance in different COPD phenotypes (Wada et al.
2018). Magnetic resonance imaging (MRI) using inhaled
noble gases was also recently used to discern the relation-
ships between low-frequency resistance and elastance as
well as the frequency dependence of resistance with MRI
signal intensity coefficients of variation (Lui et al. 2015).
Another study showed a relationship between MRI ventila-
tion defect percent (VDP) and the frequency-dependence
of resistance in COPD patients (Young et al. 2018).
While these previous results are intriguing, no large-
scale, controlled study has investigated a diversity of
patients across a spectrum of disease severities to ascer-
tain the relationships between experimental oscillometry
measurements and imaging biomarkers of airway and
parenchymal disease. This is important because in
patients with asthma and COPD, airway and parenchymal
abnormalities both contribute to symptomatic derange-
ments in lung function and poor exercise capacity. In
recent years, there has been modest clinical support for
experimental impedance measurements as a way to evalu-
ate patients (Shi et al. 2012; Lipworth and Jabbal 2018).
Accordingly, our objective was to investigate the relation-
ships between oscillometry measurements including resis-
tance, reactance and the frequency dependence of
resistance as well as AX with MRI ventilation defect mea-
surements across a wide variety of patients. In contrast
with previous investigations (Lui et al. 2015; Young et al.
2018), here we evaluated participants with asthma and
those with COPD (with and without emphysema) as well
as control groups of never-smokers without asthma and
ex-smokers without COPD.
Materials and Methods
Study participants and design
We evaluated never-smokers aged 60–90 years, asthmatics
aged 18–70 years and ex-smokers with and without
COPD aged 50–90 years who provided written informed
consent to study protocols approved by the local research
ethics board and Health Canada and registered
(NCT02483403, NCT02279329, NCT02351141 https://clini
caltrials.gov). All subjects underwent a single three-hour
study visit including spirometry, plethysmography, oscil-
lometry, and MRI. Some of these subjects were previously
evaluated and results published (Young et al. 2018).
Never-smokers performed all testing without administra-
tion of a short-acting bronchodilator. Participants with
asthma and all ex-smokers performed all testing after
administration of a short-acting bronchodilator. In addi-
tion, all ex-smokers underwent post-bronchodilator tho-
racic CT. Post-bronchodilator testing was performed
20 min after administration of four inhaled doses of
100 lg Novo-Salbutamol HFA (Teva Novopharm Ltd.,
Toronto, ON, Canada) through a pressurized metered-
dose inhaler using an AeroChamber Plus spacer (Trudell
Medical International, London, ON, Canada).
Pulmonary function tests
Spirometry and plethysmography were performed using a
MedGraphics Elite Series plethysmograph (MGC Diagnos-
tics Corporation, St. Paul, MN, USA). Spirometry was
performed according to American Thoracic Society
(ATS)/European Respiratory Society (ERS) guidelines
(Miller et al. 2005) to measure the forced expiratory vol-
ume in one-second (FEV1), forced vital capacity (FVC)
and FEV1/FVC, while plethysmography was performed to
measure lung volumes and airways resistance (Raw). For
never-smokers and all ex-smokers, the diffusing capacity
of the lung for carbon monoxide (DLCO) was also mea-
sured using a stand-alone gas analyzer attached to the
plethysmograph. For post-bronchodilator testing in
asthma, ex-smoker and COPD subgroups, participants
withheld short-acting b-agonists for 6 h, long-acting b-
agonists for 12 h and long-acting muscarinic antagonists
for 24 h before their study visit.
Oscillometry
Oscillometry was performed using the tremoFlo C-100
Airwave Oscillometry System (Thorasys, Montreal, QC,
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Canada) with the non-harmonic composite airwaves in
the adult frequency range consisting of 5, 11, 13, 17,
19, 23, 29, 21, and 37 Hz to measure total respiratory
system resistance at 5 Hz (R5), frequency-dependence of
resistance as R at 5 Hz minus R at 19 Hz (R5-19), reac-
tance at 5 Hz (X5), resonant frequency (fres) and AX. AX
was calculated by integrating the reactance curve from
5 Hz to fres and when fres was greater than 37 Hz, the
reactance curve was truncated at 37 Hz and integrated
up to that point. Participants were seated comfortably
with legs uncrossed and supported their chin and cheeks
with their hands to limit upper airway shunt. Oscillom-
etry measurements were acquired over 16 sec and
repeated for three acceptable and repeatable tests, as
judged by a coefficient of variation in resistance at 5 Hz
(CVR5) of <15%. Artefacts were automatically identified
and removed by the manufacturer’s automated algo-
rithms. Calibration of the oscillometry unit was per-
formed daily using the vendor-provided nominal
2 cmH2Os/L reference test load.
Image acquisition and analysis
All subjects underwent anatomical proton (1H) followed
by hyperpolarized 3He static ventilation MRI (within
5 min) using a whole body 3T system (MR750 Discovery,
General Electric Healthcare, Milwaukee, WI) with broad-
band imaging capability as previously described (Parraga
et al. 2007). 3He gas was polarized to 30–40% polariza-
tion (HeliSpin; Polarean Inc., Durham, NC, USA) and
diluted with N2 gas to 25%
3He by volume. Subjects were
positioned supine in the scanner with their arms above
their head and instructed to inhale 1.0 L of gas (100% N2
for 1H MRI, 3He/N2 mixture for
3He MRI) from func-
tional residual capacity (FRC) and coronal images were
acquired in 8–15 sec under breath-hold conditions. For
all image acquisition, FRC was assumed to be the lung
volume at end tidal expiration.
Hyperpolarized 3He MR images were analyzed using in-
house segmentation software as previously described (Guo
et al. 2015). Briefly, a single user placed seeds on the 1H
and 3He images to label the lung and the surrounding back-
ground tissue and image registration and segmentation
were completed automatically. 3He images were segmented
into five clusters of signal intensity using three-dimensional
k-means clustering (Kirby et al. 2012), and the ventilation
defect percent (VDP) was quantified as the ventilation
defect volume normalized to the thoracic cavity volume.
Ex-smoker participants were transported from the MRI
suite to the CT suite by wheelchair to avoid exercise-
induced dilatation of the airways. Thoracic CT volumes
were acquired within 10 min of completion of MRI using
a 64-slice LightSpeed VCT system (General Electric
Healthcare) as previously described (Owrangi et al. 2013)
under breath-hold conditions after full inspiration. The
total effective dose for each CT scan was 1.8 mSv as cal-
culated using the manufacturer’s settings and the
ImPACT patient dosimetry calculator (based on the UK
Health Protection Agency NRPB-SR250 software).
Thoracic CT images were analyzed using Pulmonary
Workstation 2.0 (VIDA Diagnostics Inc., Coralville, IA,
USA) to quantify emphysema using the relative area of the
lung <950 Hounsfield units (RA950). An RA950 threshold
of 6.8% was used to stratify COPD subjects with and with-
out CT evidence of emphysema such that RA950 ≥ 6.8%
defined presence of emphysema (Gevenois et al. 1996).
Statistical analysis
Data were tested for normality using the Shapiro-Wilk
test using IBM SPSS Statistics 25.0 (IBM Corporation,
Armonk, NY, USA) and when not normally distributed,
nonparametric statistics were performed. One-way
ANOVA and Kruskal–Wallis H test were performed for
group-wise differences with post-hoc least significant dif-
ference and Holm-Bonferroni correction to adjust for
multiple comparisons and Fisher’s exact test was used for
categorical variables using SPSS. Univariate relationships
were evaluated using Pearson correlations (r) for normally
distributed data and Spearman correlations (q) when the
data were not normally distributed using GraphPad Prism
7.00 (GraphPad Software, La Jolla, CA, USA). Multivari-
able models were generated in SPSS using the enter
approach to determine the contributions of R5, R5-19, X5,
and AX to VDP using age, sex and body mass index
(BMI) as covariates for four separate models: (1) all sub-
jects, (2) never-smokers and ex-smokers with and without
COPD, (3) ex-smokers with and without COPD, and (4)
asthmatics only. Results were considered statistically sig-
nificant when the probability of making a Type I error
was less than 5% (P < 0.05).
Results
We evaluated 175 participants including 42 elderly never-
smokers (74  7 years), 49 participants with asthma
(48  12 years; n = 14 treatment steps 1–2, n = 35 treat-
ment steps 3–4 as per the Global Initiative for Asthma
[GINA] guidelines (Global Initiative for Asthma (GINA),
2017)), 28 ex-smokers without COPD (70  9 years) and
56 ex-smokers with COPD (73  9 years; n = 18 mild
[GOLD I], n = 22 moderate [GOLD II], n = 16 severe
[GOLD III-IV]). Table 1 shows demographic, pulmonary
function test and imaging measurements for never-smo-
kers, asthma participants, ex-smokers, and COPD partici-
pants and between-group differences are shown in
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Figure 1 for select data. We note that for 10 participants,
fres was greater than 37 Hz (n = 1 asthma, n = 9 COPD).
Participants with COPD had significantly worse post-
bronchodilator pulmonary function than never-smoker
and ex-smoker participants, whereas participants with
asthma did not have significantly different post-broncho-
dilator oscillometry measurements than never-smokers
and ex-smokers. There were no significant differences
between never-smoker and ex-smoker subgroups.
Figure 2 shows 3He MRI ventilation defects and oscil-
lometry plots for two representative participants in each
group: one with low (normal) VDP and one with greater
(abnormal) VDP. For participants with asthma and
COPD, worse ventilation heterogeneity qualitatively
reflected increased frequency dependence of resistance
and reactance as well as greater AX. Increased ventilation
heterogeneity in never-smokers and ex-smokers without
COPD, however, did not reflect qualitatively apparent
changes in oscillometry. As shown quantitatively in Fig-
ure 3, in asthma and COPD participants, post-bronchodi-
lator VDP was significantly related to R5-19, X5, and AX,
but not R5. For never-smokers, VDP was significantly
negatively related to R5 only and there were no relation-
ships in ex-smokers (not shown).
Table 2 shows multivariable models that predict VDP
from oscillometric parameters R5, R5-19, X5 and AX. R5
(b = 0.22, P = 0.01) and X5 (b = 0.34, P = 0.03) sig-
nificantly added to the prediction of VDP for all subjects
(Model 1: R = 0.63, R2 = 0.39, P < 0.0001). For never-
smokers and ex-smokers with and without COPD, R5
(b = 0.48, P = 0.001), R5-19 (b = 0.35, P = 0.03), and X5
(b = 0.41, P = 0.03) significantly added to the prediction
of VDP (Model 2: R = 0.66, R2 = 0.44, P < 0.0001),
whereas for only ex-smokers with and without COPD, the
overall model was significant (Model 3: R = 0.62,
R2 = 0.38, P < 0.0001) but none of the oscillometry
parameters significantly added to the model. The overall
model was also significant for asthmatic participants only
(Model 4: R = 0.65, R2 = 0.43, P = 0.001) but none of the
oscillometry parameters significantly added to the model.
Of the 56 COPD participants evaluated, 33 had CT evi-
dence of emphysema (RA950 ≥ 6.8%) (Gevenois et al.
1996) and 23 had no CT evidence of emphysema
(RA950 < 6.8%). VDP was not significantly related to R5
regardless of the presence of emphysema, but VDP was
related to AX in COPD with (q = 0.39, P = 0.02) and
without emphysema (q = 0.43, P = 0.04). VDP and R5-19
were significantly related in COPD subjects without
Table 1. Subject demographics
Parameter mean (SD) Never-smokers (n = 42) Asthma (n = 49) Ex-smokers (n = 28) COPD (n = 56) Sig diff* (P)
Age, years 74 (7) 48 (13) 70 (9) 73 (9) <0.0001
Male, n (%) 21 (50) 19 (39) 16 (57) 36 (64) 0.1
BMI, kg/m2 27 (4) 28 (5) 31 (4) 26 (4) <0.0001
FEV1%pred 107 (18) 77 (21) 102 (19) 68 (27) <0.0001
FVC, %pred 103 (15) 88 (15) 95 (19) 92 (21) 0.002
FEV1/FVC, % 77 (6) 69 (13) 80 (6) 53 (12) <0.0001
RV, %pred 98 (22) 121 (33) 100 (21) 148 (47) <0.0001
TLC, %pred 100 (13) 102 (15) 96 (13) 113 (18) <0.0001
RV/TLC, %pred 96 (17) 118 (23) 104 (16) 129 (26) <0.0001
DLCO, %pred 90 (16) – 87 (17) 61 (23) <0.0001
Raw, %pred 83 (38) 105 (51) 65 (24) 117 (49) <0.0001
R5, cmH2Os/L 3.59 (1.68) 4.25 (1.49) 3.32 (1.12) 3.64 (1.23) 0.7
R5-19, cmH2Os/L 0.54 (0.76) 0.82 (0.87) 0.36 (0.54) 0.96 (0.79) 0.001
X5, cmH2Os/L 1.41 (0.88) 1.86 (1.26) 1.42 (0.72) 2.41 (1.57) 0.001
fres, Hz
1 19.77 (7.40) 19.53 (6.86) 20.20 (5.78) 23.66 (7.67) 0.001
AX, cmH2O/L 12.94 (14.94) 14.38 (14.90) 9.79 (7.57) 23.30 (19.96) 0.008
VDP % 3 (2) 5 (6) 5 (4) 19 (12) <0.0001
SD = standard deviation; Sig diff = significance of difference; BMI = body mass index; FEV1 = forced expiratory volume in one-second;
%pred = percent predicted; FVC = forced vital capacity; RV = residual volume; TLC = total lung capacity; DLCO = diffusing capacity of the lung
for carbon monoxide; Raw = airways resistance measured using plethysmography; R5 = respiratory system resistance at 5 Hz; R5-19 = frequency
dependence of resistance; X
5
= respiratory system reactance at 5 Hz; fres = resonant frequency; AX = reactance area; VDP = ventilation defect
percent.
Pre-bronchodilator values shown for never-smokers and post-bronchodilator values shown for asthmatics, ex-smokers and COPD subjects.
*Significance of difference calculated using one-way ANOVA for parametric variables and Kruskal–Wallis H test for nonparametric variables;
significant values are bolded.
1n = 42 for never-smokers, n = 48 for asthma, n = 28 for ex-smokers, n = 47 for COPD; fres > 37 Hz for remaining subjects.
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emphysema only (q = 0.54, P = 0.008), and significantly
related to X5 in COPD subjects with emphysema only
(q = 0.36, P = 0.04). There was no CT evidence of
emphysema (all RA950 < 6.8%) in ex-smokers without
spirometry evidence of airflow limitation based on GOLD
criteria of FEV1/FVC < 0.7 (Global Initiative for Chronic
Obstructive Lung Disease (GOLD), 2017).
Discussion
We evaluated oscillometry and hyperpolarized 3He MRI
measurements in a relatively large group of patients with
asthma and COPD as well as two control groups and
made four important observations: (1) in asthma and
COPD participants, VDP was significantly but weakly cor-
related with R5-19, X5, and AX, but not R5, (2) in COPD
patients without emphysema, VDP was related only to
R5-19 and AX, and only X5 and AX in COPD patients with
emphysema, (3) in an ex-smoker control group, there
were no significant relationships while in never-smokers,
only VDP and R5 were related, and, (4) AX was weakly
related to VDP in all subgroups with airflow obstruction,
demonstrating its sensitivity to airflow obstruction but
not specificity to type of obstruction.
The relationship between oscillometry and MRI
VDP with quality-of-life measurements was previously
Figure 1. Pulmonary function test and MRI VDP measurements. (A) Significantly lower FEV1 in asthma and COPD compared to never-smokers
and ex-smokers. (B) Significantly greater RV/TLC in asthma and COPD compared to never-smokers and ex-smokers. (C) Significantly greater Raw
in asthma as compared to ex-smokers and COPD subjects and significantly greater Raw in COPD as compared to never and ex-smokers. (D)
Significantly greater VDP in COPD as compared to all other subgroups. (E) R5 not significantly different between all subgroups. (F) Significantly
greater R5-19, and, (G) Significantly more negative X5, and, (H) significantly greater AX in COPD as compared to never- and ex-smokers.
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investigated in 100 patients (Young et al. 2018) and this
previous work was in agreement with our observations.
The fact that there were no significant relationships
between VDP and oscillometry in the control subgroups
except for R5 and VDP in never-smokers is also congru-
ent with previous results (Young et al. 2018). Based on
Figure 2. Relationship between MRI ventilation heterogeneity and impedance measurements in representative subjects. Centre slice coronal
static ventilation 3He MRI (cyan) co-registered to anatomical 1H (grey-scale) and corresponding oscillometry plots for two representative asthma,
COPD, never-smoker and ex-smoker participants. Worse ventilation heterogeneity qualitatively reflected increased frequency dependence of
resistance and reactance as well as greater AX in participants with asthma and COPD, but not for never-smokers and ex-smokers without
COPD.
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this previous work, our results were not unexpected. R5
reflects the resistance of the entire respiratory system
including all airways (and not the just the small airways
or the larger airways) and this may explain why signifi-
cant relationships with VDP were not present. R5 was also
not significantly different between the four subgroups,
whereas R5-19, X5, AX as well as plethysmography-mea-
sured airways resistance (Raw) were. This suggests that R5
is not sensitive to the differences in resistance in our
patient population and this could be because much of the
resistance in these patients may be due to the peripheral
airways and this effect is overshadowed in the R5 signal.
Oscillometry measurements that reflect the heterogeneity
of airway narrowing (R5-19) as well as X5 and AX (Tgava-
lekos et al. 2007; Dellaca et al. 2009) were all related to
VDP in asthma and all COPD patients, and none of these
relationships were detected in never- or ex-smokers.
Notably, ventilation defects in severe COPD were previ-
ously shown to be related to both emphysema and small
airways disease (Kirby et al. 2013; Capaldi et al. 2016) so
the negative relationship between VDP and X5 in COPD
was not surprising. This was not previously observed
(Young et al. 2018) perhaps due to the current study’s
larger sample size across all grades of COPD severity. It
has been shown in experimental studies in humans and
animals however, that the major influence of heterogene-
ity is its impact on resistance and elastance between
0.1 Hz and 5 Hz (Hantos et al. 1986, 1990; Tepper et al.
1992), whereas our system is limited to 5 Hz and above.
We are thus only capturing the “tail-end” of the impact
of heterogeneities using R5-19 and this may explain the
weak correlations observed.
Figure 3. Quantitative relationships between MRI VDP and
impedance measurements. (A) VDP was not significantly related to
R5 in asthma nor in COPD subjects. (B) VDP was significantly
related to R5-19, and, (C) X5 and, (D) AX in asthma and COPD
participants.
Table 2. Multivariable models to predict VDP from oscillometry
Unstandardized
Standardized
PVariable B Standard error b
MODEL 1: All subjects, n = 175 (R = 0.63; R2 = 0.39, P < 0.0001)
R5 1.98 0.77 0.22 0.01
R5-19 1.81 1.61 0.15 0.3
X5 2.75 1.26 0.34 0.03
AX 0.13 0.11 0.21 0.2
MODEL 2: Never-smokers, ex-smokers with and without COPD,
n = 126 (R = 0.66, R2 = 0.44, P < 0.0001)
R5 3.96 1.17 0.48 0.001
R5-19 5.14 2.35 0.35 0.03
X5 3.55 1.63 0.41 0.03
AX 0.10 0.13 0.15 0.5
MODEL 3: Ex-smokers with and without COPD, n = 84 (R = 0.62;
R2 = 0.38, P < 0.0001)
R5 2.95 1.93 0.29 0.1
R5-19 6.24 3.41 0.39 0.07
X5 1.16 2.20 0.14 0.6
AX 0.18 0.17 0.27 0.3
MODEL 4: Asthma only, n = 49 (R = 0.65, R2 = 0.43, P = 0.001)
R5 1.28 0.84 0.20 0.1
R5-19 3.33 1.85 0.49 0.08
X5 1.15 1.36 0.24 0.4
AX 0.14 0.13 0.36 0.3
VDP = ventilation defect percent; R5 = resistance at 5 Hz; R5-
19 = resistance at 5 Hz minus resistance at 19 Hz; X5 = reactance
at 5 Hz; AX = reactance area.
Covariates: age, sex, BMI.
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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To better understand how oscillometry and MRI VDP
measurements are related and may explain the biome-
chanical impact of obstructive lung disease in patients, we
generated multivariable models. We were surprised to
observe that R5 significantly contributed to the models
with all subjects (Model 1) and in never-smokers and ex-
smokers with and without COPD (Model 2). R5 did not
significantly contribute to the models in ex-smokers with
and without COPD (Model 3) or in asthmatics (Model
4). Based on these differences it is possible that the R5
results were being driven by the never-smoker subgroup
in whom there is no airflow obstruction. There were no
significant coefficients in Model 3 and 4 which may be
due to the smaller subgroup sizes which limited power to
detect significant contributions. However, R5-19 has the
greatest relative influence on VDP in Models 3 and 4
which did not include the never-smoker group.
COPD patients can be phenotyped based on the pres-
ence of airways disease and emphysema (Hogg et al.
2004) and these phenotypes also reflect differences in
lung biomechanics and function (Wada et al. 2018). We
observed differences in the relationships between VDP
and oscillometry measurements in COPD patients with
and without emphysema, although it is likely that all
COPD patients had airways disease too. The fact that X5
and AX were related to VDP in emphysematous COPD
patients suggests that X5 and AX may reflect parenchy-
mal stiffness or derecruitment, resulting in ventilation
defects. In contrast, in COPD patients with little or no
emphysema, VDP was related to AX and R5-19 indicative
of heterogeneous airway narrowing largely in the periph-
ery, which was in agreement with previous work (Smith
et al. 2005). The different behaviours of R5-19 and X5 in
COPD patients with and without emphysema suggests
that X5 measures a different component that is indepen-
dent of heterogeneous airway obstruction associated with
R5-19 (Otis et al. 1956). However, AX was weakly signifi-
cantly related to VDP in patients with and without
emphysema, and this suggests that it is nonspecific to
the type of obstruction (either airways disease or
emphysema) in COPD patients. Emphysematous and
airways disease phenotypes may be best identified by
appropriate use of R5-19 and X5. In COPD patients, it is
also important to acknowledge that airways disease and
emphysema phenotypes are typically observed in combi-
nation (Nakano et al. 2000), so future examinations
should also evaluate mixed phenotypes which were not
evaluated here.
AX was originally developed to improve the signal-to-
noise ratio of respiratory system reactance compared to
reactance values at a single frequency (Goldman 2001).
Table 3 provides an overview of the advantages and limi-
tations of oscillometry measurements of obstructive lung
disease including AX. It is clear that AX is sensitive to air-
flow obstruction, however it is nonspecific to the type of
obstruction and cannot distinguish airway constriction
from lung recruitment or parenchymal stiffening. R5-19 on
the other hand is known to reflect obstruction in the dis-
tal airways (Grimby et al. 1968) whereas X5 is known to
reflect elastic components of the lung. Moreover, AX and
the frequency dependence of resistance may depend on
the number and choice of harmonics in the forcing wave-
form making them variable in different settings. For AX,
the largest influence is the first harmonic since this is
where the most of the area is located, and different com-
mercially available devices start at different frequencies
anywhere from 4 Hz for adults up to 8 Hz for children.
Our data also demonstrated that for COPD participants
Table 3. Advantages and limitations of oscillometry measurements
Advantages Limitations
Frequency dependence of resistance (R5-19)
• Signal averaging minimizes noise and potential artefacts
• Differentiates proximal from distal obstruction
• Detects mild/early obstruction
• Variable in different settings
Reactance at 5 Hz (X5)
• Reflects elastic components
• Reflects peripheral airway disease
• More noise
• Nonspecific to obstruction versus restriction
Reactance area (AX)
• Sensitive to obstruction
• Signal averaging minimizes noise and potential artefacts
• Units of cmH2O/L, similar to elastance
• Sensitive to intra-subject response to therapy or provocation
• Nonspecific to type of obstruction
• Variable in different settings
• When fres is undefined, Ax value is user-defined
(hence variable between different devices)
• Weakly related to inter-subject differences
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with markedly abnormal AX greater than 50 cmH2O/L,
VDP values ranged from 5% to 45% (Fig. 3D) and this
suggests that AX is weakly related to inter-subject VDP
differences. We note that AX did not significantly con-
tribute to VDP in any of the multivariable models. The
multiple correlation coefficients ranged from 0.62 to 0.66
with R2 = 0.39–0.44, so together, the oscillometry param-
eters contributed to no more than 44% of the variability
in VDP regardless of subgroup.
We also recognize a number of other study limita-
tions. Hyperpolarized 3He MRI is unlikely to be clini-
cally used because of the vanishing global quantities and
exorbitant cost of 3He (Shea and Morgan 2010). 129Xe
MRI is more sensitive to airway obstruction (Kirby
et al. 2013; Svenningsen et al. 2013), less costly and
therefore, more feasible for clinical examinations so it
will be important to compare oscillometry and 129Xe
MRI measurements in patients. Moreover, shunting of
the oscillatory waves to the upper airways reduces sensi-
tivity to obstruction despite firm cheek-holding (Cau-
berghs and van de Woestijne 1989). This means that in
patients with obstruction, impedance may be underesti-
mated, which may have also limited the correlation
strengths observed here. We note that the never-smoker
control group studied here underwent testing without
inhaled bronchodilators whereas asthmatics, ex-smokers
and COPD ex-smokers were evaluated post-bronchodila-
tor. We previously showed that there was no post-
bronchodilator MRI ventilation response in elderly
never-smokers (Sheikh et al. 2014) with ventilation
abnormalities, so we expect no confounding effects due
to the lack of post-bronchodilator measurements in this
subgroup. Finally, we also acknowledge positional differ-
ences in the oscillometry (seated upright) and MRI
measurements (supine). Respiratory system resistance is
increased in the supine position compared to upright
(Lorino et al. 1992; Gonzales et al. 2017) and the pres-
ence of emphysema also causes large upright to supine
AX variability (Dandurand et al. 2015), which may also
explain why the relationships observed here were weak
to moderate.
To our knowledge, this is the largest controlled evalua-
tion of oscillometry and functional MRI undertaken in
patients and healthy volunteers. The pattern of significant
relationships for VDP with R5-19 and X5 was different
between the different disease subgroups (i.e., COPD with
and without emphysema, asthma). On the other hand,
the relationship of AX with VDP was similar across dis-
ease subgroups, suggesting that AX is a sensitive but not
specific measurement of obstruction. The different rela-
tionships for MRI VDP with R5-19 and X5 may reflect air-
way and parenchymal disease-specific biomechanical
abnormalities that lead to ventilation defects.
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We evaluated the relationships between hyperpolarized 3He ventilation defect percent (VDP) and respiratory system resis-
tance, reactance and AX oscillometry measurements in 175 participants. R5-19 and X5 demonstrated different relationships
with VDP in patients with different disease phenotypes, whereas AX was weakly related to VDP in all subgroups with air-
flow obstruction. Our results demonstrated that AX is sensitive to obstruction but not specific to the type of obstruction,
and that the different relationships for MRI VDP with R5-19 and X5 may reflect airway and parenchymal disease-specific
biomechanical abnormalities that lead to ventilation defects.
